Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo effect after apomorphine conditioning on rigidity and subthalamic nucleus neuron activity in Parkinson's disease
2005-000431-22Phase 4Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of apomorphine in Parkinson's disease (PD) (2 arms), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoints: Change in motor rigidity and Change in electrical activity of subthalamic nucleus neurons. Started Sep 2005; status: active.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2005-000431-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000431-22.